ADAR1 (RNA‐editing enzyme can lead to the creation of missense mutations in coding sequences) is highly expressed in lung cancer tissues, which also increases the expression of tumor cells such as M0 and M2 macrophages, but decreases the levels of CD4+ T cells in the effector immune cells. This evidence concerns the gene CD4 and neoplasm.